Yasmin Alternatives Compared
| Yasmin (drospirenone / ethinyl estradiol) | Mirena (levonorgestrel) | Nexplanon (etonogestrel) |
|
|---|
| Yasmin (drospirenone / ethinyl estradiol) | Mirena (levonorgestrel) | Nexplanon (etonogestrel) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Premenstrual Dysphoric Disorder, Acne, Birth Control. Yasmin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Heavy Menstrual Bleeding, Birth Control. Mirena may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Birth Control. Nexplanon may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||||||||||||||||||
| More about Yasmin (drospirenone / ethinyl estradiol) | More about Mirena (levonorgestrel) | More about Nexplanon (etonogestrel) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Yasmin has an average rating of 5.2 out of 10 from a total of 605 ratings on Drugs.com. 37% of reviewers reported a positive effect, while 43% reported a negative effect. |
Mirena has an average rating of 6.1 out of 10 from a total of 2624 ratings on Drugs.com. 46% of reviewers reported a positive effect, while 32% reported a negative effect. |
Nexplanon has an average rating of 5.0 out of 10 from a total of 4864 ratings on Drugs.com. 32% of reviewers reported a positive effect, while 43% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Yasmin side effects |
View all Mirena side effects |
View all Nexplanon side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Yasmin prices |
View all Mirena prices |
View all Nexplanon prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other drospirenone / ethinyl estradiol brands include: Gianvi, Jasmiel, Lo-Zumandimine, Loryna, Melamisa, Nikki, Ocella, Syeda, Yaela, Yaz, Zarah, Zumandimine View more | Other levonorgestrel brands include: Aftera, AfterPill, AfterPlan, Athentia Next, Curae, EContra One-Step, Fallback Solo, Her Style, Julie, Kyleena, Liletta, Morning After, My Choice, My Way, New Day, Next Choice One Dose, Opcicon One-Step, Option 2, Optionelle, Plan B One-Step, PostDay One-Step, SheWise, Skyla, Take Action View more |
N/A |
||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
32.5 hours |
45 hours |
25 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 569 drugs are known to interact with Yasmin:
|
A total of 258 drugs are known to interact with Mirena:
|
A total of 246 drugs are known to interact with Nexplanon:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
May 11, 2001 |
N/A |
July 17, 2006 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.